Skip to menu
Skip to content
Skip to footer
Menu
Study
Research
Partners and community
About
Search
About
Faculties, schools, institutes and centres​
Strategic initiatives and projects
Strategic initiatives and projects
Office of 2032 Games Engagement
Office of 2032 Games Engagement
Strategy and governance
Our impact
Our experts
Our experts
Sport, health and inclusion
A better future for our environment
Economy of the future
Connecting people and places
The Queensland Commitment
University projects
University projects
Avalon Theatre restoration
UQ Experts
Academic Calendar
Study
Research
Partners and community
About
UQ home
News
Events
Give
Contact
Search term
UQ home
News
Events
Give
Contact
UQ home
About
UQ Experts
A phase 3 multicentre, randomised, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of aducanumab (BIIB037) in subjects with early Alzheimer's Disease
A phase 3 multicentre, randomised, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of aducanumab (BIIB037) in subjects with early Alzheimer's Disease (2015-2019)
Experts
Professor Gerard Byrne
Mayne Professor of Psychiatry
Medical School (Office & AME)
Faculty of Medicine
Mayne Professor of Psychiatry
Medical School
Faculty of Medicine
Gerard Byrne
